Oloctinebart Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5263
Add to Compare
$695.00
Delivery Time : 4 weeks
Add to Wish List
More Information
Concentration 5mg/ml
isotype IgG4 - kappa
Host CHO Cells
Target LGALS3
Species Reactivity Human
Specificity Detects human LGALS3
Purification Method This monoclonal antibody was purified using Protein A
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity >95% by SDS-PAGE
Endotoxin ² 1.0 EU/mg as determined by the LAL method
Storage This biosimilar is stable when stored at 2-8¡C. For longer term storage (> 3 months) it is recommended to store this antibody at -20¡C or -70¡C.
Applications Functional Assays
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time 4 weeks
Write Your Own Review
You're reviewing:Oloctinebart Biosimilar - Research Grade
Your Rating
Who Viewed This Also Viewed
Anti-Mouse MHC Class I H-2Kb (AF6-88.5) In Vivo Antibody - Low Endotoxin
Anti-Mouse MHC Class I H-2Kb (AF6-88.5) In Vivo Antibody - Low Endotoxin
$390.00 - $2,885.00
Retifanlimab Biosimilar - Research Grade
Retifanlimab Biosimilar - Research Grade
$732.00 - $19,500.00
Trastuzumab Biosimilar - APC Research Grade
Trastuzumab Biosimilar - APC Research Grade
$255.00
Tabalumab Biosimilar - HRP Research Grade
Tabalumab Biosimilar - HRP Research Grade
$357.00
Mouse IgG1 (HKSP) Isotype Control for In Vivo - Low Endotoxin
Mouse IgG1 (HKSP) Isotype Control for In Vivo - Low Endotoxin
$350.00 - $3,702.00
Anti-CD11C (N418) In Vivo Antibody - Low Endotoxin
Anti-CD11C (N418) In Vivo Antibody - Low Endotoxin
$390.00 - $2,885.00
Lenzilumab Biosimilar - Research Grade
Lenzilumab Biosimilar - Research Grade
$306.00 - $19,500.00
Anti-Human TIGIT (4E1.2) In Vivo Antibody - Low Endotoxin
Anti-Human TIGIT (4E1.2) In Vivo Antibody - Low Endotoxin
$390.00 - $2,885.00
Abrilumab Biosimilar - Research Grade
Abrilumab Biosimilar - Research Grade
$306.00 - $19,500.00
Tildrakizumab Biosimilar - Research Grade
Tildrakizumab Biosimilar - Research Grade
$732.00 - $19,500.00
Back to Top